logo

For the Inventor, By the Inventor

CA

Pharmacor Inc.


USPTO Granted Patents = 12

% Expired Patents = 16.7

Forward Citations = 89

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Gilles Sauvé (11 out of 11 patents)

silverMedal Brent Richard Stranix (9 out of 20 patents)

bronzeMedal Abderrahim Bouzide (8 out of 16 patents)

4.  Jocelyn Yelle (8 out of 8 patents)

5.  Alexandre Coté (5 out of 5 patents)

6.  Patrick Soucy (5 out of 5 patents)

7.  Yongsen Zhao (5 out of 5 patents)

8.  Gervais Bérubé (5 out of 5 patents)

9.  Guy Sévigny (2 out of 2 patents)

10.  Nicolas Leberre (1 out of 3 patents)

11.  Valérie Perron (1 out of 1 patent)

12.  Jean-François Lavallée (1 out of 1 patent)

13.  Blaise Magloire N'Zemba (1 out of 1 patent)


12 patents:

1. 6677367 - HIV protease inhibitors based on amino acid derivatives (2004-01-13),
2. 6656965 - HIV protease inhibitors based on amino acid derivatives (2003-12-02),
3. 6638921 - Pyridoxal-5-phosphate derivatives as HIV integrase inhibitors (2003-10-28),
4. 6632816 - Aromatic derivatives as HIV aspartyl protease inhibitors (2003-10-14),
5. 6610689 - HIV protease inhibitors based on amino acid derivatives (2003-08-26),
6. 6608100 - HIV protease inhibitors based on amino acid derivatives (2003-08-19),
7. 6528655 - Aromatic derivatives with HIV integrase inhibitory properties (2003-03-04),
8. 6528532 - Urea derivatives as HIV aspartyl protease inhibitors (2003-03-04),
9. 6506786 - HIV protease inhibitors based on amino acid derivatives (2003-01-14),
10. 6455587 - Amino acid derivatives as HIV aspartyl protease inhibitors (2002-09-24),
11. 6362165 - Hydroxyphenyl derivatives with HIV integrase inhibitory properties (2002-03-26),
12. 6313177 - D-mannitol derivatives as HIV aspartyl protease inhibitors (2001-11-06),
Company Overview
Pharmacor Inc. is a Canadian company specializing in the development and manufacturing of innovative pharmaceutical products. The organization focuses on advancing therapeutic solutions across various medical fields, including oncology, neurology, and infectious diseases. With a commitment to research and development, Pharmacor leverages cutting-edge technologies to enhance drug efficacy and patient outcomes. Its strategic initiatives aim to address unmet medical needs and improve healthcare delivery through novel therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#97 in

#1,265 in Canada

#48,129 in the World

CA
CA

Pharmacor Inc.

Forward Citations = 89

13 inventors:

goldMedal Gilles Sauvé (11 out of 11 patents)

silverMedal Brent Richard Stranix (9 out of 20 patents)

bronzeMedal Abderrahim Bouzide (8 out of 16 patents)

4.  Jocelyn Yelle (8 out of 8 patents)

5.  Alexandre Coté (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmacor Inc.. Retrieved from https://idiyas.com/company/pharmacor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…